Estée Lauder
Up to $5,000
Claims opening soon
A $120 million settlement was reached for those who indirectly purchased Lovenox or its generic equivalent enoxaparin.
Class action settlement for consumers who indirectly purchased Lovenox or enoxaparin due to alleged price-fixing.
This settlement resolves claims related to alleged price-fixing of the blood thinner Lovenox and its generic equivalent enoxaparin. Eligible claimants who indirectly purchased these drugs may have received compensation from the $120 million fund.
Closed settlement
Claim status: Claim window closed
Estée Lauder
Up to $5,000
Claims opening soon
Silk and Great Value
Up to $300,000
96 days left
Audible
Compensation pending
Claims opening soon
Government of Canada
Up to $200,000
746 days left

Meta (Facebook)
Up to $90
Claims opening soon
Ticketmaster
Compensation pending
Claims opening soon